Noriko Nishinarita

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer

Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara et al. · PLoS ONE · 2019 · 39 citations · Full text

<p>Impact of <em>EGFR </em>genotype on the efficacy of osimertinib in <em>EGFR </em>tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study</p>

Satoshi Igawa, Taihei Ono, Masashi Kasajima et al. · Cancer Management and Research · 2019 · 23 citations · Full text

Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non‐small cell lung cancer harboring an <i>EGFR</i> mutation: A prospective observational study

Taihei Ono, Satoshi Igawa, Takahiro Ozawa et al. · Thoracic Cancer · 2019 · 17 citations · Full text

Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease

Satoshi Igawa, Noriko Nishinarita, Akira Takakura et al. · Cancer Management and Research · 2018 · 13 citations · Full text

Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status

Satoshi Igawa, Masayuki Shirasawa, Takahiro Ozawa et al. · Thoracic Cancer · 2018 · 11 citations · Full text